X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Caladrius Biosciences

    By 2030, Offshore Formulation Development To Be Worth $60bn

    US Gives Lynparza Priority Review If Paired With Abiraterone

    NHS To Offer Variant-Busting Booster Before The Winters

    NHS To Offer Variant-Busting Booster Before The Winters

    Evidence Shows Alzheimer Benefits From Genuv Cancer Drug

    Evidence Shows Alzheimer Benefits From Genuv Cancer Drug

    Auvelity- A Possible Game Depression Treatment, Says Axsome

    Auvelity- A Possible Game Depression Treatment, Says Axsome

    Bluebird Gene Therapy Given FDA Nod Despite Safety Issues

    FDA Approves Zynteglo $2.8M Gene Treatment From Bluebird Bio

    Merck Establishes Strategic Oncology Collaboration with Taiho and Astex

    ADCs Developed By Starpharma Will Be Evaluated By Merck

    Bayer Hires Lobbyists After Roe To Push Contraception Access

    Trodelvy Scores A Breast Cancer Survival Win For Gilead

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Caladrius Biosciences

    By 2030, Offshore Formulation Development To Be Worth $60bn

    US Gives Lynparza Priority Review If Paired With Abiraterone

    NHS To Offer Variant-Busting Booster Before The Winters

    NHS To Offer Variant-Busting Booster Before The Winters

    Evidence Shows Alzheimer Benefits From Genuv Cancer Drug

    Evidence Shows Alzheimer Benefits From Genuv Cancer Drug

    Auvelity- A Possible Game Depression Treatment, Says Axsome

    Auvelity- A Possible Game Depression Treatment, Says Axsome

    Bluebird Gene Therapy Given FDA Nod Despite Safety Issues

    FDA Approves Zynteglo $2.8M Gene Treatment From Bluebird Bio

    Merck Establishes Strategic Oncology Collaboration with Taiho and Astex

    ADCs Developed By Starpharma Will Be Evaluated By Merck

    Bayer Hires Lobbyists After Roe To Push Contraception Access

    Trodelvy Scores A Breast Cancer Survival Win For Gilead

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development Clinical Trials

New Analysis Supports Medisafe’s Impact on Medication Persistence, Adherence

Content Team by Content Team
9th July 2021
in Clinical Trials, Drug Development, News
New Analysis Supports Medisafe's Impact on Medication Persistence, Adherence
Previous Post

Cellenkos Selects Cryoport to Support On-Demand, Flexible COVID-19 Therapy Shipments to Patients in Need

 Next Post

Fujitsu Japan Embarks on Joint Research for COVID-19 Therapies Using Fugaku

Related Posts

Caladrius Biosciences
Drug Development

By 2030, Offshore Formulation Development To Be Worth $60bn

25th August 2022
Pharma Contract Manufacturing Market To Be $130bn By 2026
Manufacturing

Pharma Contract Manufacturing Market To Be $130bn By 2026

25th August 2022
Integrity Bio Announces Newly Validated Biotech Manufacturing Line
Manufacturing

Forecasting Biopharma Contract Manufacturing Trends In 2022

25th August 2022
Usual Pharma Compliance Issues Noted In FDA Warning Letters
Facilities & Operation

Usual Pharma Compliance Issues Noted In FDA Warning Letters

25th August 2022
CRISIL Expects Indian Pharma Sales To Climb 7%-9% In FY23
Facilities & Operation

CRISIL Expects Indian Pharma Sales To Climb 7%-9% In FY23

25th August 2022
FDA Approvals

US Gives Lynparza Priority Review If Paired With Abiraterone

24th August 2022
Next Post
Fujitsu Japan Embarks on Joint Research for COVID-19 Therapies Using Fugaku

Fujitsu Japan Embarks on Joint Research for COVID-19 Therapies Using Fugaku

Latest News

Caladrius Biosciences
Drug Development

By 2030, Offshore Formulation Development To Be Worth $60bn

25th August 2022
Pharma Contract Manufacturing Market To Be $130bn By 2026
Manufacturing

Pharma Contract Manufacturing Market To Be $130bn By 2026

25th August 2022
Integrity Bio Announces Newly Validated Biotech Manufacturing Line
Manufacturing

Forecasting Biopharma Contract Manufacturing Trends In 2022

25th August 2022
Usual Pharma Compliance Issues Noted In FDA Warning Letters
Facilities & Operation

Usual Pharma Compliance Issues Noted In FDA Warning Letters

25th August 2022
CRISIL Expects Indian Pharma Sales To Climb 7%-9% In FY23
Facilities & Operation

CRISIL Expects Indian Pharma Sales To Climb 7%-9% In FY23

25th August 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In